Harris has reaped a windfall of campaign funds since Democrats backed her to replace President Joe Biden after he withdrew ...

Cantor Fitzgerald initiated coverage of Amgen with an Overweight rating and $405 price target. The firm views Amgen’s obesity ...

On Sept. 27, Howard Lutnick, the CEO of financial Cantor Fitzgerald, appeared on Fox Business and urged regulators to ...

Cantor Fitzgerald has recently initiated Innoviva Inc (INVA) stock to Overweight rating, as announced on June 18, 2024, according to Finviz. Earlier, on July 20, 2022, Goldman had initiated the stock ...

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 0.35% of ...

Cantor Fitzgerald Large Cap Focused Fund earns an Above Average Process Pillar rating. The most significant contributor to the rating is the parent firm's five-year risk-adjusted success ratio of ...

It is still down more than 50% since the start of the year. Cantor Fitzgerald analyst Andres Sheppard told Reuters the capital injection was major progress and that Polestar's gross margin of a ...

As the crypto industry gears up for the 2024 election, there’s a growing narrative that a win for former President Donald ...

In the wake of the company's financial report, Cantor Fitzgerald analyst Derek Soderberg maintained his overweight (buy) ...

While momentous, the approval of Cobenfy could also draw attention to an age-old problem in American healthcare: Will insurance barriers keep patients from getting an effective medicine?

Amgen (AMGN) is up more than +1% after Cantor Fitzgerald initiated coverage on the stock with a recommendation of overweight with a price target of $405. HP Inc. (HPQ) is down more than -4% to lead ...

Amgen (AMGN) closed up more than +1% after Cantor Fitzgerald initiated coverage on the stock with a recommendation of overweight with a price target of $405. Globe Life (GL) closed down more than -4% ...